Work

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria

Year: 2011

Type: article

Source: Diagnostic Microbiology and Infectious Disease

DOI: 10.1016/j.diagmicrobio.2011.03.002

Authors: Michael A. Pfaller, David Andes, Maiken C. Arendrup, Daniel J. Diekema, Ana Espinel-Ingroff, Barbara D. Alexander, Steven D. Brown, Vishnu Chaturvedi, Cynthia L. Fowler, Mahmoud A. Ghannoum, Elizabeth M. Johnson, Cynthia C. Knapp, Mary R. Motyl, Luis Ostrosky-Zeichner, Thomas J. Walsh

Institutions: University of Iowa, University of Wisconsin–Madison, Statens Serum Institut, Virginia Commonwealth University Medical Center, Duke University, New York State Department of Health, bioMérieux (United States), Case Western Reserve University, Merck & Co., Inc., Rahway, NJ, USA (United States), The University of Texas Health Science Center at Houston, Cornell University

Language: English

Topic: Antifungal resistance and susceptibility

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2129135057

FWCI: 15.34

Cites: 70

Cited by: 130

Related to: 10